Wound Care & Rare Disease Diagnosis
June 28, 2021
Stay tuned as we discuss innovations in wound healing and care, plus Behind the Mystery of systemic mastocytosis, a rare disease that can cause patients to live in fear.
First up, BlastX is a breakthrough antimicrobial wound gel powered by Next Science’s patented, non-toxic, biofilm-disruption Xbio™ technology.
Then, we’ll meet Kristine who spent years struggling with symptoms of systemic mastocytosis causing her to live in fear of potential triggers, and hematologist/oncologist Dr. Bose to help understand the complicated aspects of this rare disease.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.